“To understand innovation you should ask "why not?" and not "why?" Selling (blockchain) is a problem and people and companies are blocking adoption which prevents innovation within a company, and stymies costs savings and  efficientcy - that is the problem.  It's a problem to be stuck in an innovation department - blockchain needs to be used in operations. Scientists and technologists need to understand one another better to create opportunity and success" - Raja Sharif, CEO, ATMPS In 2022, the team at ATMPS  launched a potential game changer with a new approach to cell and gene therapy tracking, allowing more streamlined applications, payment options, and opportunity to realize true manufacturing safety and trust at scale, faster for personalized medicines and regimen treatments. The speaker highlights his experiences, and overcomes market challenges empasizing the need for better commercialization strategies for blockchain. In addition, the fllowing topics are addressed in the keynote: Automated Processes Regulatory Visibility & Compliance, FDA 21 CFR , HIPAA, GDPR Putting Together Blockchain Architecture for IRTS & ERH Integration Patient Apps and Mobile Device Issues Supply Chain

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.